Stocks
Pfizer (PFE) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 333.5% | 337.0% | 510.1% | 353.2% | 270.7% | 407.7% | |||
| Changes by years, y/y, % | -31pp | +4pp | +173pp | -157pp | -82pp | -5.8% | |||
Pfizer. R&D/CAPEX, %
Pfizer. R&D/CAPEX, changes, pp
Pfizer (PFE) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 287.6% | 331.1% | 265.6% | 352.3% | 407.7% | |||
| Changes by years, y/y, % | -87pp | +11pp | -96pp | -219pp | +133pp | |||
| Changes by quarters, q/q, % | +69pp | +43pp | -65pp | -266pp | ||||
